Literature DB >> 1713813

Serum CD14 levels in polytraumatized and severely burned patients.

C Krüger1, C Schütt, U Obertacke, T Joka, F E Müller, J Knöller, M Köller, W König, W Schönfeld.   

Abstract

Recently it has been demonstrated that the CD14 molecule which is expressed on monocytes and macrophages serves as a receptor for lipopolysaccharide (LPS) bound to LPS-binding protein (LBP) and thus mediates LPS-induced tumour necrosis factor (TNF) production. Here we report that CD14 is found as a soluble (s) molecule in serum. In healthy volunteers sCD14 levels (mean +/- s.e.m.) were 3.7 +/- 0.05 micrograms/ml (n = 30, 25-50 years of age) as determined by ELISA (detection limit 20 ng/ml serum) using two monoclonal antibodies in a sandwich technique. In polytraumatized patients (n = 16) significantly decreased levels (1.7 +/- 0.3) were detected immediately after the trauma, which increased to 4.9 +/- 0.3 micrograms/ml within the first 6 days post trauma. sCD14 remained elevated during the first 14 days post trauma in patients with the most severe injuries (injury severity score greater than 45 points), whereas a return to normal levels was observed in patients with an injury score of less than 45 points. In addition, the levels of the high-density lipoproteins that partially inactivate free endotoxin are significantly decreased post trauma. No correlation between parameters of inflammation (C3a and neopterin levels, leucocyte counts, amount of band cells), liver function and sCD14 levels was established. Comparable to polytraumatized patients, increased sCD14 serum levels were observed in five patients with burn trauma (burned area greater than 35%) within the second week post trauma when clinical signs of septicaemia were evident.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713813      PMCID: PMC1535761          DOI: 10.1111/j.1365-2249.1991.tb05722.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

Authors:  O Westphal
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

Review 2.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

3.  Human monocyte activation induced by an anti-CD14 monoclonal antibody.

Authors:  C Schütt; B Ringel; M Nausch; V Bazil; V Horejsí; P Neels; H Walzel; L Jonas; E Siegl; H Friemel
Journal:  Immunol Lett       Date:  1988-12       Impact factor: 3.685

Review 4.  Posttraumatic multisystem organ failure.

Authors:  M M DeCamp; R H Demling
Journal:  JAMA       Date:  1988 Jul 22-29       Impact factor: 56.272

5.  Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein.

Authors:  P S Tobias; K Soldau; R J Ulevitch
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

6.  Metabolism of platelet activating factor (PAF) and lyso-PAF in polymorphonuclear granulocytes from severely burned patients.

Authors:  W Schönfeld; S Kasimir; M Köller; G Erbs; F E Müller; W König
Journal:  J Trauma       Date:  1990-12

7.  Studies on the mechanisms of granulocyte dysfunctions in severely burned patients--evidence for altered leukotriene generation.

Authors:  M Köller; W König; J Brom; G Erbs; F E Müller
Journal:  J Trauma       Date:  1989-04

Review 8.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

9.  Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum.

Authors:  P S Tobias; K P McAdam; K Soldau; R J Ulevitch
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

View more
  34 in total

1.  Increased levels of circulating soluble CD14 in Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Tsujimoto; Y Kawamura; H Kawase; I Sekine
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.

Authors:  D Filipp; K Alizadeh-Khiavi; C Richardson; A Palma; N Paredes; O Takeuchi; S Akira; M Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Increased levels of soluble CD14 in sera of periodontitis patients.

Authors:  J Hayashi; T Masaka; I Ishikawa
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.

Authors:  Diana Rose E Ranoa; Stacy L Kelley; Richard I Tapping
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

5.  Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities.

Authors:  Cristian Palmiere; Michele Mussap; Daniel Bardy; Francesco Cibecchini; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-12-22       Impact factor: 2.686

6.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 7.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

8.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome.

Authors:  Sun Kwon Kim; Roberto Romero; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Pooja Mittal; Offer Erez; Edi Vaisbuch; Francesca Gotsch; Percy Pacora; Lami Yeo; Maria Teresa Gervasi; Ronald F Lamont; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

10.  Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.

Authors:  E J von Asmuth; M A Dentener; V Bazil; M G Bouma; J F Leeuwenberg; W A Buurman
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.